Related Experiment Video
Updated: Jul 20, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Serum fetuin-A levels link inflammation and cardiovascular calcification in hemodialysis patients
Mario Cozzolino1, Andrea Galassi, Maria Luisa Biondi
1Renal Division, S. Paolo Hospital, University of Milan, Milan, Italy. mariocozzolino@hotmail.com
Insights
Reduced fetuin-A levels are linked to widespread cardiovascular calcifications (CVC) in hemodialysis (HD) patients. Lower fetuin-A indicates a higher risk of CVC, independent of other risk factors.
Area of Science:
- Nephrology
- Cardiology
- Biochemistry
Background:
- Cardiovascular disease (CVD) is the primary cause of death in hemodialysis (HD) patients.
- Cardiovascular calcifications (CVC) are prevalent in HD patients and linked to inflammation and mortality.
- Fetuin-A is a key inhibitor of CVC, and its reduced levels correlate with increased cardiovascular risk.
Purpose of the Study:
- To investigate the association between serum fetuin-A levels and the extent of CVC in hemodialysis patients.
- To determine if fetuin-A levels predict CVC independently of traditional cardiovascular risk factors.
Main Methods:
- A cohort of 115 hemodialysis patients (vintage >or=9 months) was evaluated.
- Cardiovascular calcifications (CVC) were assessed using ultrasound imaging across multiple sites, quantified as a Cardiovascular Calcification Score (CVCS).
- Patients were stratified into groups based on CVCS (0, <6, and >=6). Serum fetuin-A, C-reactive protein, and fibrinogen levels were measured.
Main Results:
- Patients with CVC in more than 5 sites had significantly lower serum fetuin-A levels compared to those without CVC (p=0.048).
- A higher CVCS was associated with elevated C-reactive protein (p=0.002) and fibrinogen (p<0.001).
- Serum fetuin-A levels below 0.290 g/l were independently associated with a higher risk of a worse CVCS.
Conclusions:
- Chronic inflammation in hemodialysis patients contributes to reduced serum fetuin-A levels.
- This study confirms a significant, independent association between lower serum fetuin-A levels and multi-site CVC in hemodialysis patients.
Background:
Cardiovascular disease (CVD) is the leading cause of mortality in hemodialysis (HD). An elevated incidence of cardiovascular calcifications (CVC) is observed in HD. Fetuin-A is an important inhibitor of CVC. Reduced fetuin-A levels associate with inflammation and increased cardiovascular (CV) mortality in HD. In this study we investigated the association of fetuin-A levels and CVC.
Method:
We evaluated a cohort of 115 patients (67 males), aged 63 +/- 16 years with a HD vintage >or=9 months. Presence of CVC was assessed by ultrasound imaging of the abdominal aorta, common carotid arteries, bilateral ilio-femoral axis, aortic and mitral cardiac valves. The presence of CVC was analyzed as a CVC score (CVCS) (0-7) according to the number of CVC sites. Patients were arbitrary stratified in three groups: group I (CVCS = 0), group II (0 < CVCS < 6) and group III (CVCS >or= 6). Patients without CVC were younger, non-diabetic and with a negative history for CV events.
Results:
Patients with evidence of CVC in more than 5 sites had lower serum fetuin-A levels (0.41 +/- 0.22 g/l) compared to patients with CVCS = 0 (0.51 +/- 0.17 g/l, p = 0.048). In addition a worse CVCS was associated with higher serum levels of C-reactive protein (p = 0.002) and fibrinogen (p < 0.001). Serum fetuin-A levels lower than 0.290 g/l were associated with higher risk of a worse CVCS, independently from traditional risk factors.
Conclusion:
Chronic inflammation in HD patients leads to lower serum fetuin-A levels. The present study confirms the independent and significant association between reduced serum fetuin-A levels and multi-site CVC in HD.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Serum Studies: Renal Function Tests
Nephrotic Syndrome II : Assessment and Medical Management
Hemodialysis I: Introduction
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Chronic Kidney Disease III: Interprofessional Care
